Soleno Therapeutics, Inc. Common Stock
SLNO
SLNO: Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome.
moreShow SLNO Financials
Recent trades of SLNO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SLNO's directors and management
Government lobbying spending instances
-
$40,000 Jul 19, 2023 Issue: Pharmacy
-
$20,000 Apr 20, 2023 Issue: Pharmacy
New patents grants
-
Patent Title: Resuscitation bag Jul. 20, 2021
Federal grants, loans, and purchases
Followers on SLNO's company Twitter account
Number of mentions of SLNO in WallStreetBets Daily Discussion
Recent insights relating to SLNO
Recent picks made for SLNO stock on CNBC
ETFs with the largest estimated holdings in SLNO
Flights by private jets registered to SLNO